Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,110
- 试验地点
- 1
- 主要终点
- Prevalence of HLA-B*5701 in European HIV-1 population
研究概览
简要总结
This study is a cross-sectional observational study to evaluate the prevalence of HLA-B*5701 in the European area and in major European ethnotypes.
Any HIV-1 infected patient will be eligible for this study including treatment naïve and experienced patients, as well as patients previously tested for HLA-B*5701. Patients will be approached during a standard clinic visit, and will be consented prior to any study specific procedure. They will be asked to provide a tissue sample (cheek cells and blood sample) which will be used to assess HLA-B*5701 status by local and central laboratories.
In selected sites patients may be asked to provide an additional blood sample. This sample will be used to develop and validate different methodologies for assessing HLA-B*5701 status.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Prevalence of HLA-B*5701 in European HIV-1 population
次要结局
- Prevalence of HLA-B*5701 in major European ethnotypes